India's chance to drive the global narrative through the G20 presidency

22 May 2023
india_night_big

With its G20 presidency, India has a unique opportunity to remove trade barriers for its pharmaceutical products in many countries, the domestic drug industry has told the Indian government.

Asking the government to negotiate to remove trade barriers, industry stalwarts have urged the government to lead in the development of a G20 prequalification system or an alternative pathway to market access for drugs that would be similar to the WFP qualification system.

In the G20, major economies representing more than 80% of the world's GDP and 75% of its trade convene at an international level.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical